Letters

Cost effectiveness of lowering cholesterol

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7065.1142 (Published 02 November 1996) Cite this as: BMJ 1996;313:1142

Cost consequence analysis may be more useful to decision makers

  1. J Shepherd
  1. Professor of pathological biochemistry On behalf of the WOSCOPS Economic Evaluation Committee Institute of Biochemistry, Royal Infirmary, Glasgow G4 0SF

    EDITOR,—If economic analyses are to provide guidance on population health strategies they should consider all relevant costs and consequences associated with medical interventions. We have identified five methodological deficiencies in the economic analysis of P D P Pharoah and W Hollingworth.1

    Firstly, their study examines the impact of treatment only on death; it ignores the value of averting non-fatal consequences such as unstable angina, myocardial infarction, revascularisation procedures, and stroke. These consequences decrease both the length and quality of patients' lives.2 3 By …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe